Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medications that mimic a hormone released in the intestines after a meal. Its effect impacts feelings of fullness and appetite.
Driven by diabetes and obesity usage, GLP-1s are in high demand across the nation.
Subsequently, the U.S. Food and Drug Administration (FDA) has reported a shortage of GLP-1s ─ or medications containing semaglutide ─ in their Current Drug Shortages database.
Express Scripts does not have access to inventory data for network pharmacies. We recommend contacting your local retail pharmacy to ask whether they have any medication in stock.